ClinicalTrials.Veeva

Menu

Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community (MOSAR)

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Methicillin-Resistant Staphylococcus Aureus
ESBL Infection

Study type

Observational

Funder types

Other

Identifiers

NCT00773799
TASMC-08-YC-239-CTIL

Details and patient eligibility

About

Data on occurrence of antimicrobial resistant bacteria acquisition in rehabilitation centers will be collected. After removal of patient identifiers, information regarding the patients population will be entered into electronic sheet. The phase will last twelve months in each center.

Full description

All patients admitted to the department will be examined on admission, two weeks latter and monthly by obtaining nares and perirectal cultures. These cultures will be processed for detection the target organisms. This activity is part of the good medical practice and is performed on routine basis in various hospital units

Epidemiological data will be collected from patient records. This data will be stored after removal of all patients' identifiers. These data will be transferred for analysis to Tel Aviv Medical Center

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized patients are older then 18 years old

Exclusion criteria

  • Age 18 years or less

Trial design

1,200 participants in 1 patient group

rehabilitation center's hospitalized patients

Trial contacts and locations

1

Loading...

Central trial contact

yaffa lerman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems